Ser130
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser130  -  RHEB (human)

Site Information
LHMERVIsYEEGkAL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 18157800

In vivo Characterization
Methods used to characterize site in vivo:
[32P] ATP in vitro ( 1 ) , immunoprecipitation ( 1 ) , mass spectrometry (in vitro) ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
293 (epithelial) ( 1 ) , E.coli (bacterial) ( 1 ) , MEF (fibroblast) ( 1 )

Upstream Regulation
Putative in vivo kinases:
MAPKAPK5 (human) ( 1 )
Kinases, in vitro:
MAPKAPK5 (mouse) ( 1 )
Treatments:
2-deoxyglucose ( 1 ) , acadesine ( 1 )

Downstream Regulation
Effects of modification on RHEB:
activity, inhibited ( 1 ) , phosphorylation ( 1 )
Inhibit interaction with:
Other ( 1 )

References 

1

Zheng M, et al. (2011) Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat Cell Biol 13, 263-72
21336308   Curated Info